Careprost is a medication with the active ingredient bimatoprost. It is also known by other names, such as Lumigan and Latisse. It is used to treat high eye pressure or glaucoma and is also popular for growing longer, thicker eyelashes.
The cost of the Careprost varies from £29.95 to £34.04 per bottles. Depending on the size of the pack and the number of tablets inside (1 or 10 ml).
Careprost (Bimatoprost) is primarily used to reduce intraocular pressure (IOP) in individuals with glaucoma or ocular hypertension. It falls under the class of prostaglandin analogs. Bimatoprost is also popular for cosmetic use to stimulate eyelash growth, leading to longer, thicker, and darker eyelashes.
The active ingredient in Careprost is Bimatoprost at a concentration of 0.03%. This compound mimics the naturally occurring prostaglandin and helps increase the outflow of aqueous humor within the eye, reducing intraocular pressure and promoting eyelash growth.
Careprost is indicated for patients with open-angle glaucoma or ocular hypertension. It’s also used as a treatment for hypotrichosis of the eyelashes, where the goal is to increase eyelash length, thickness, and darkness.
For glaucoma or ocular hypertension, one drop should be administered in the affected eye(s) once daily in the evening. For eyelash growth, it should be applied to the upper eyelid at the base of the eyelashes with a sterile applicator. Avoid applying to the lower eyelid.
Bimatoprost lowers intraocular pressure by increasing the drainage of aqueous humor through the trabecular meshwork and uveoscleral pathways. For eyelash growth, it lengthens the anagen phase (growth phase) of the hair follicle cycle, leading to increased length and thickness of the eyelashes.
Careprost should be stored at a temperature between 2°C and 25°C (36°F and 77°F). Keep the bottle tightly closed when not in use to prevent contamination. Avoid exposure to extreme light and moisture. Do not freeze.
This medication should not be used by individuals who are allergic to Bimatoprost or any other component of the solution. It is also contraindicated in patients with active eye infections, severe eye injuries, or those who have undergone ocular surgery recently.
Common side effects include eye irritation, dry eyes, redness of the eye, and eyelid darkening. Less common side effects may involve changes in iris color, increased sensitivity to light, and vision disturbances. Consistent use on the skin around the eyes may result in skin darkening.
Careprost may interact with other medications used to lower intraocular pressure. Inform healthcare providers about all ophthalmic and systemic medications in use. Using multiple prostaglandins simultaneously can counteract their effects, and concurrent use with certain beta-blockers may enhance IOP reduction.
Ensure hands and applicators are clean before application to avoid contamination. Do not let the dropper tip touch any surfaces, including the eyes or hands. The product is for topical external use only and should not be ingested or applied to other body parts.
If a dose is missed, administer it as soon as remembered unless it is close to the time of the next dose. Do not double up the dose to make up for a missed one. Resume the usual dosing schedule as laid out by the healthcare provider.
Consult a healthcare provider to confirm eligibility for Careprost, especially for individuals who are pregnant, planning to conceive, or breastfeeding. Not recommended for pediatric use or in individuals under 16 years of age.
Do not use Careprost past its expiration date. Dispose of unused or expired medication in accordance with local regulations. Avoid disposing of it via wastewater or household waste. Consult a pharmacist for proper disposal methods to ensure environmental safety.
If you decide to stop using Careprost for eyelash growth, gradual reduction in eyelash length, thickness, and darkness is expected. Consult with a healthcare provider for guidance on tapered discontinuation to monitor any adverse effects.
Use cautiously in patients with ocular inflammation or edema. Elderly patients may exhibit a similar response to the medication as younger adults, but individual adjustment for renal or hepatic function may be necessary. Safety and efficacy in children have not been established.
Regular follow-up appointments are necessary to monitor intraocular pressure and visual fields. Continuous monitoring ensures that the medication is effectively reducing IOP and not causing adverse effects on the optic nerve or vision.
For IOP reduction, significant results can be seen within a few weeks of consistent use. For eyelash growth, visible improvement begins at around eight weeks with full results in 12-16 weeks. Consistency and adherence to the regimen are crucial for achieving desired outcomes.
Prior to initial application, shake the bottle well and inspect the solution for particles or discoloration. If any abnormalities are observed, do not use it. Follow the specific steps provided by the healthcare provider meticulously to ensure proper administration.
Clinical trials have demonstrated that Careprost significantly reduces IOP in patients with glaucoma or ocular hypertension compared to placebo. It has shown superior efficacy in eyelash enhancement over other available treatments. Long-term studies support its sustained efficacy and safety profile.
Any unexpected side effects or reactions should be reported immediately to a healthcare provider or pharmacist. Documenting these events assists in managing and mitigating any potential risks associated with the use of Careprost.
Careprost typically comes in a 3 ml sterile ophthalmic solution bottle with a dropper tip. The packaging includes instructions for use and safety information. Ensure the seal is intact before the first use to guarantee product integrity.